Somatostatin acts in CA1 and CA3 to reduce hippocampal epileptiform activity

Journal of Neurophysiology

Volumn 81, Issue 4, 1999, Pages 1626-1635

  Tallent, Melanie K ^a   Siggins, George R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICUCULLINE; MAGNESIUM ION; SOMATOSTATIN;

ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; EPILEPSY; EPILEPTIC DISCHARGE; EXCITATORY POSTSYNAPTIC POTENTIAL; FACILITATION; HIPPOCAMPUS; MALE; MOSSY FIBER; NERVE CELL STIMULATION; NERVE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033054087     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.1999.81.4.1626     Document Type: Article

References (72)

1. ANNEGERS, J. F. Epidemiology and genetics of epilepsy. Neurol. Clin. 12: 15-29, 1994.
2. ASHWOOD, T. J. AND WHEAL, H. V. Extracellular studies on the role of N-methyl-D-aspartate receptors in epileptiform activity recorded from the kainic acid-lesioned hippocampus. Neurosci. Lett. 67: 147-152, 1986.
3. BEN-ARI, Y. AND GHO, M. Long-lasting modification of the synaptic properties of rat CA3 hippocampal neurones induced by kainic acid. J. Physiol. (Lond.) 404: 365-384, 1988.
4. BERRY, M. S. AND PENTREATH, V. W. Criteria for distinguishing between monosynaptic and polysynaptic transmission. Brain Res. 105: 1-20, 1976.
5. BOEHM, S. AND BETZ, H. Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors. J. Neurosci. 17: 4066-4075, 1997.
6. CAPOGNA, M., GÄHWILER, B. H., AND THOMPSON. S. M. Mechanism of muopioid receptor-mediated presynaptic inhibition in the rat hippocampus in vitro. J. Physiol. (Lond.) 470: 539-558, 1993.
7. CHRISTIAN, E. P. AND DUDEK, F. E. Electrophysiological evidence from glutamate microapplications for local excitatory circuits in the CA1 of rat hippocampal slices. J. Neurophysiol. 59: 110-123, 1988.
8. CLAIBORNE, B. J., XIANO, Z., AND BROWN, T. H. Hippocampal circuitry complicates analysis of long-term potentiation in mossy fiber synapses. Hippocampus 3: 115-121, 1993.
9. CREPEL, V., KHAZIPOV, R., AND BEN-ARI, Y. Blocking GABA(A) inhibition reveals AMPA- and NMDA-receptor-mediated polysynaptic responses in the CA1 region of the rat hippocampus. J. Neurophysiol. 77: 2071-2082, 1997.
10. DE LANEROLLE, N. C., KIM, J. H., ROBBINS, R. J., AND SPENCER, D. D. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 495: 387-395, 1989.
11. DEUCHARS, J. AND THOMSON, A. M. CA1 pyramid-pyramid connections in rat hippocampus in vitro: dual intracellular recordings with biocytin filling. Neuroscience 74: 1009-1018, 1996.
12. DINGLEDlNE, R., HYNES, M. A., AND KING, G. L. Involvement of N-methyl-D-aspartate receptors in epileptiform bursting in the rat hippocampal slice. J. Physiol. (Lond.) 380: 175-189, 1986.
13. DODD, J. AND KELLY, J. S. Is somatostatin an excitatory neurotransmitter in the hippocampus. Nature 273: 674-675, 1978.
14. FREUND, T. F. AND BUZSAKI, G. Interneurons of the hippocampus. Hippocampus 6: 347-470, 1996.
15. GEREAU, R. W. AND CONN, P. J. Presynaptic enhancement of excitatory synaptic transmission by β-adrenergic receptor activation. J. Neurophysiol. 72: 1438-1442, 1994.
16. HIGUCHI, T., SIKAND, G. S., KATO, N., WADA, J. A., AND FRIESEN, H. G. Profound suppression of kindled seizures by cysteamine: possible role of somatostatin to kindled seizures. Brain Res. 288: 359-362, 1983.
17. HÖKFELT, T. Neuropeptides in perspective: the last ten years. Neuron 7: 867-879, 1991.
18. JOHNSTON, D. AND BROWN, T. H. The synaptic nature of the paroxysmal depolarizing shift in hippocampal neurons. Ann. Neurol 16: S65-S71, 1984.
19. KLAPSTEIN, G. J. AND COLMERS, W. F. On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro. Hippocampus 3: 103-111, 1993.
20. KORN, S. J., GIACCHINO, J. L., CHAMBERLIN, N. L., AND DINGLEDINE, R. Epileptiform burst activity induced by potassium in the hippocampus and its regulation by GABA-mediated inhibition. J. Neurophysiol. 57: 325-340, 1987.
21. LAHTINEN, H., MIETTINEN, R., YLINEN, A., HALONEN, T., AND RIEKKINEN, P. S. Biochemical and morphological changes in the rat hippocampus following transection of the fimbria-fornix. Brain Res. Bull. 31: 311-318, 1993.
22. LE BEAU, F.E.N. AND ALGER, B. E. Transient suppression of GABAA-receptor-mediated IPSPs after epileptiform burst discharges in CA1 pyramidal cells. J. Neurophysiol. 79: 659-669, 1998.
23. LERANTH, C., MALCOLM, A. J., AND FROTSCHER, M. Afferent and efferent synaptic connections of somatostatin- immunoreactive neurons in the rat fascia dentata. J Comp. Neurol. 295: 111-122, 1990.
24. LEROUX, P., WEISSMANN, D., PUJOL, J.-F., AND VALDRY, H. Quantitative autoradiography of somatostatin receptors in the rat limbic system. J. Comp. Neurol. 331: 389-401, 1993.
25. MANABE, T., WYLLIE, D., PERKEL, D. J., AND NICOLL, R. A. Modulation of synaptic transmission and long-term potentiation in the CA1 region of the hippocampus. J. Neurophysiol. 70: 1451-1459, 1993.
26. MANFRIDI, A., FORLONI, G. L., VEZZANI, A., FODRITTO, F., AND DE SIMONI, M. G. Functional and histological consequences of quinolinic and kainic acid-induced seizures on hippocampal somatostatin neurons. Neuroscience 41: 127-135, 1991.
27. MARTIN, J.-L., CHESSELET, M.-F., RAYNOR, K., GONZALES, C., AND REISINE, T. Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs. Neuroscience 41: 581-593, 1991.
28. MATHERN, G. W., BABB, T. L., PRETORIUS, J. K., AND LEITE, J. P. Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata. J. Neurosci. 15: 3940-4004, 1995.
29. MAZARATI, A. M. AND TELEGDY, G. Effects of somatostatin and anti-somatostatin serum on picrotoxin-kindled seizures. Neuropharmacology 31: 793-797, 1992.
30. MCNAMARA, J. O. Cellular and molecular basis of epilepsy. J Neurosci. 14: 3413-3425, 1994.
31. MEIER, C. L. AND DUDEK, F. E. Spontaneous and stimulation-induced synchronized burst afterdischarges in the isolated CA1 of kainate-treated rats. J. Neurophysiol. 76: 2231-2239, 1996.
32. MEIER, C. L., OBENAUS, A., AND DUDEK, F. E. Persistent hyperexcitability in isolated hippocampal CA1 of kainate-lesioned rats. J. Neurophysiol. 68: 2120-2127, 1992.
33. MILNER, T. A. AND BACON, C. E. Ultrastructural localization of somatostatin-like immunoreactivity in the rat dentate gyrus. J. Comp. Neurol. 290: 544-560, 1989.
34. MITCHELL, J., GATHERER. M., AND SUNDSTROM, L. E. Loss of hilar somatostatin neurons following tetanus toxin-induced seizures. Acta Neuropathol. (Berl.) 89: 425-430, 1995.
35. MODY, I. AND HEINEMANN, U. NMDA receptors of dentate gyrus granule cells participate in synaptic transmission following kindling. Nature 326: 701-704, 1987.
36. MODY, I., LAMBERT, J. D., AND HEINEMANN, U. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J. Neurophysiol. 57: 869-888, 1987.
37. MONNO, A., RIZZI, M., SAMANIN, R., AND VEZZANI, A. Anti-somatostatin antibody enhances the rate of hippocampal kindling in rats. Brain Res. 602: 148-152, 1993.
38. MOORE, S. D., MADAMBA, S. G., JOËLS, M., AND SIGGINS, G. R. Somatostatin augments the M-current in hippocampal neurons. Science 239: 278-280, 1988.
39. PEREZ, J., VEZZANI, A., CIVENNI, G., TUTKA, P., RIZZI, M., SCHUEPBACH, E., AND HOYER, D. Functional effects of D-Phe-c[Cys-Tyr-D-Trp-Lys-Val-Cys]-Trp-NH2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats. Neuroscience 65: 1087-1097, 1995.
40. PEREZ, Y., MORIN, F., BEAULIEU, C., AND LACAILLE, J. C. Axonal sprouting of CA1 pyramidal cells in hyperexcitable hippocampal slices of kainate-treated rats. Ear. J. Neurosci. 8: 736-748, 1996.
41. PERLIN, J. B., LOTHMAN, E. W., AND GEARY, W. A. Somatostatin augments the spread of limbic seizures from the hippocampus. Ann. Neurol. 21:475-480, 1987.
42. PITTMAN, Q. J. AND SIGGINS, G. R. Somatostatin hyperpolarizes pyramidal cells in vitro. Brain Res. 221: 402-408, 1981.
43. PIWKO, C., THOSS, V. S., SAMANIN, R., HOYER, D., AND VEZZANI, A. Status of somatostatin receptor messenger RNAs and binding sites in rat brain during kindling epileptogenesis. Neuroscience 75: 857-868, 1996.
44. ROBBINS, R. J., BRINES, M. L., KIM, J. H., ADRIAN, T., DE LANEROLLE, N., WELSH, S., AND SPENCER, D. D. A selective loss of somatostatin in the hippocampus of patients with temporal lobe epilepsy. Ann. Neurol. 29: 325-332, 1991.
45. SALIN, P. A., SCANZIANI, M., MALENKA, R. C., AND NICOLL, R. A. Distinct short-term plasticity at two excitatory synapses in the hippocampus. Proc. Natl. Acad. Sci. USA 93: 13304-13309, 1996.
46. SCHARFMAN, H. E. AND SCHWARTZKROIN, P. A. Further studies of the effects of somatostatin and related peptides in area CA1 of rabbit hippocampus. Cell. Mol. Neurobiol. 8: 411-429, 1988.
47. SCHARFMAN, H. E. AND SCHWARTZKROIN, P. A. Selctive depression of GABA-mediated IPSPs by somatostatin in area CA1 of rabbit hippocampal slices. Brain Res. 493: 205-211, 1989.
48. SCHULZ, P. E., COOK, E. P., AND JOHNSTON, D. Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation. J. Neurosci. 14: 5325-5337, 1994.
49. SCHWARTZKROIN, P. A. AND PRINCE, D. A. Cellular and field potential properties of epileptogenic hippocampal slices. Brain Res. 147: 117-130, 1978.
50. SCHWARTZKROIN, P. A. AND PRINCE, D. A. Changes in excitatory and inhibitory synaptic potentials leading to epileptogenic activity. Brain Res. 183: 61-76, 1980.
51. SCHWARZER, C., WILLIAMSON, J. M., LOTHMAN, E. W., VEZZANI, A., AND SPERK, G. Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience 69: 831-845, 1995.
52. SCHWEITZER, P., MADAMBA, S., CHAMPAGNAT, J., AND SIGGINS, G. R. Somatostatin inhibition of hippocampal CA1 pyramidal neurons: mediation by arachidonic acid and its metabolites. J. Neurosci. 13: 2033-2049, 1993.
53. SCHWEITZER, P., MADAMBA, S., AND SIGGINS, G. R. Arachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current. Nature 346: 464-467, 1990.
54. + conductance in rat CA1 hippocampal neurons. J. Neurophysiol. 79: 1230-1238, 1998.
55. SLOVITER, R. S. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science 235: 73-76, 1987.
56. SLOVITER, R. S. The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy. Ann. Neurol. 35: 640-654, 1994.
57. TALLENT, M. K. AND SIGGINS, G. R. Somatostatin depresses excitatory but not inhibitory neurotransmission in rat CA1 hippocampus. J. Neurophysiol. 78: 3008-3018, 1997.
58. TALLENT, M. K. AND SIGGINS, G. R. Somatostatin depresses epileptiform activity by reducing feed-forward excitation in rat hippocampus. Soc. Neurosci. Abstr. 24: 2044, 1998.
59. TAUCK, D. L. AND NADLER, J. V. Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. J. Neurosci. 5: 1016-1022, 1985.
60. 2+ in the rat hippocampal slice. J. Physiol. (Lond.) 478: 379-393, 1994.
61. TRAUB, R. D. AND WONG, R. K. Cellular mechanism of neuronal synchronization in epilepsy. Science 216: 745-747, 1982.
62. TRAYNELIS, S. F. AND DINGLEDINE, R. Potassium-induced spontaneous electrographic seizures in the rat hippocampal slice. J. Neurophysiol. 59: 259-276, 1988.
63. TURNER, D. A. AND WHEAL, H. V. Excitatory synaptic potentials in kainic acid-denervated rat CA1 pyramidal neurons. J. Neurosci. 11: 2786-2794, 1991.
64. VEZZANI, A., MONNO, A., RIZZI, M., GALLI, A., BARRIOS, M., AND SAMANIN, R. Somatostatin release is enhanced in the hippocampus of partially and fully kindled rats. Neuroscience 51: 41-46, 1992.
65. WATSON, T.W.J. AND PITTMAN, Q. J. Somatostatin(14) and -(28) but not somatostatin(1-12) hyperpolarize CA1 pyramidal neurons in vitro. Brain Res. 448: 40-45, 1988.
66. WILLIAMS, S. H. AND JOHNSTON, D. Kinetic properties of two anatomically distinct excitatory synapses in hippocampal CA3 pyramidal neurons. J. Neurophysiol. 66: 1010-1020, 1991.
67. WILLIAMSON, A., SPENCER, S. S., AND SPENCER, D. D. Depth electrode studies and intracellular dentate granule cell recordings in temporal lobe epilepsy. Ann. Neurol. 38: 778-787, 1995.
68. WILLIAMSON, R. AND WHEAL, H. V. The contribution of AMPA and NMDA receptors to graded bursting activity in the hippocampal CA1 region in an acute in vitro model of epilepsy. Epilepsy Res. 12: 179-188, 1992.
69. WONG, R. K. AND TRAUB, R. D. Synchronized burst discharge in disinhibited hippocampal slice. I. Initiation in CA2-CA3 region. J. Neurophysiol. 49: 442-458, 1983.
70. XIE, Z. AND SASTRY, B. R. Actions of Somatostatin on GABA-ergic synaptic transmission in the CA1 area of the hippocampus. Brain Res. 591: 239-247, 1992.
71. ZALUTSKY, R. A. AND NICOLL, R. A. Comparison of two forms of long-term potentiation in single hippocampal neurons. Science 248: 1619-1624, 1990.
72. ZUCKER, R. S. Changes in the statistics of transmitter release during facilitation. J. Physiol. (Lond.) 229: 787-810, 1973.